DIA 2016
Fatality in clinical trials: DIA panel discusses FIH trials
After the Bial trial tragedy earlier this year, panelists gathered at DIA to discuss what went wrong and how to move forward as an industry.
DIA 2016
After the Bial trial tragedy earlier this year, panelists gathered at DIA to discuss what went wrong and how to move forward as an industry.
Veeva Systems has introduced Veeva Vault CTMS, a new application that brings together information, documentation, and processes in the cloud.
Sartorius has expanded its bio-analytics capabilities through the $90m (€81m) acquisition of IntelliCyt.
“There are units that are doing first-in-human studies that frankly have no business doing them”
Set standards for Phase I trials could stop serious adverse events and patient deaths, says a DIA panellist discussing the recent Bial trial tragedy.
Researchers supported by the National Institutes of Health (NIH) have developed a clinical-grade stem cell line, which will help accelerate early-stage clinical research.
A recently opened facility will double production of Sanofi Pasteur’s vaccine Stamaril which could alleviate shortages in the wake of recent yellow fever outbreaks in parts of Africa.
Quality system and data integrity issues have landed two Chinese API makers with US FDA warning letters.